Chronic obstructive airways disease following treated pulmonary tuberculosis.
about
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPDChronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatmentThe association between airflow obstruction and radiologic change by tuberculosisTrends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosisA novel scoring system to measure radiographic abnormalities and related spirometric values in cured pulmonary tuberculosisLongitudinal Lung Function Decrease in Subjects with Spontaneous Healed Pulmonary TuberculosisLung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional studyDiagnosis and management of miliary tuberculosis: current state and future perspectivesIs there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transitionWheeze, asthma diagnosis and medication use: a national adult survey in a developing countryLongevity loss among cured tuberculosis patients and the potential value of preventionEffect of inhaled tiotropium on spirometric parameters in patients with tuberculous destroyed lungNon-hispanic whites have higher risk for pulmonary impairment from pulmonary tuberculosisClinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unitClinico-Radiologic and Spirometric Profile of an Indian Population with Post-Tuberculous Obstructive Airway Disease.Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics.Advancing host-directed therapy for tuberculosis.The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis.A Novel Reading Scheme for Assessing the Extent of Radiographic Abnormalities and Its Association with Disease Severity in Sputum Smear-Positive Tuberculosis: An Observational Study in Hyderabad/India.A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung DiseaseComorbidities of chronic obstructive pulmonary disease in Koreans: a population-based studyGuidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Influence of old pulmonary tuberculosis on the management of secondary spontaneous pneumothorax in patients over the age of 70 years.Prevalence and etiological profile of chronic obstructive pulmonary disease in nonsmokers.History of pulmonary tuberculosis affects the severity and clinical outcomes of COPD.Tuberculosis, Airway Obstruction and Mortality in a Finnish Population.The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD.The evaluation of general practitioners' awareness/knowledge and adherence to the GOLD guidelines in a Shanghai suburb.Evaluation of tuberculosis-associated chronic obstructive pulmonary disease at a tertiary care hospital: A case-control study.The epidemiology of noncommunicable respiratory disease in sub-Saharan Africa, the Middle East, and North AfricaThe considerable, often neglected, impact of pulmonary tuberculosis on the prevalence of COPD.Severe COPD cases from Korea, Poland, and USA have substantial differences in respiratory symptoms and other respiratory illnesses.Sequelae of pulmonary multidrug-resistant tuberculosis at the completion of treatment.Impaired pulmonary function after treatment for tuberculosis: the end of the disease?Alterations in the peripheral blood B cell subpopulations of multidrug-resistant tuberculosis patients.Tuberculosis and lung damage: from epidemiology to pathophysiology.The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed TherapyElevated interleukin-6 and bronchiectasis as risk factors for acute exacerbation in patients with tuberculosis-destroyed lung with airflow limitation
P2860
Q22241773-2777815A-758D-43E8-906C-862E457C9F90Q23912735-92D57AB6-DDE5-492B-87AD-17D5C3051A27Q28385486-7C9B7D57-4BEA-4F0D-B512-A6206AD99355Q28388618-7C8CDFA6-F063-4242-B18A-C5B3B081C9C6Q28390507-05C85897-3A99-455C-A14A-471B7C0A4FE9Q28390954-4CADF92F-92C4-4E17-A6CC-16E6358C667FQ28392846-9960A19B-2810-46D9-B51A-B72AC7BC1B3EQ28393022-6394B564-8145-45E5-8A69-BFEA0302A69DQ28393235-05FFA5AB-B0CC-43CA-B17C-C7E365E31900Q28393479-5208DAA4-5D9A-496B-89FE-3ACEC0DE1D0BQ28394151-8C005231-BC6F-41EB-8B59-50756F8785ECQ28395929-980A7696-D06F-4F86-B3F8-FF77749776F1Q28397030-0F6C03C8-A138-4A98-AB57-D655CB222009Q28397673-3C1F129E-7374-4790-ABA7-D8C6662F12ABQ30828471-213358EE-71F6-4554-9283-2B27CED5733AQ33666593-5BB2DC91-AAA9-4CED-B523-408190B1BA93Q33766481-020D619D-B0D5-4483-81B6-B1D70F9E0CAEQ34039460-82B78B45-8ACE-404D-8431-6C5944B0005AQ34466861-8814DDF1-5769-4957-9308-16F714127296Q34539996-11D2DED9-D104-4476-8251-47A64696300BQ36072967-94E98F8B-337C-42D3-96F6-91C5D306D8A5Q36102809-829261FD-87AB-42D7-9360-BFD9D017152FQ36134602-634908DD-8CB3-4643-9DEB-7E1B8D2B0C3AQ37177278-336E5D5A-E087-4692-8FD7-CDA7A49AA4DCQ37411218-4C08A280-4D00-4DEA-9A7C-5E972B8B8244Q37701181-53EEF8A1-8D5A-4093-A1EE-AF4485178E45Q38606125-0C4D7645-AA5C-4590-BD94-71FE31C66626Q39158779-0F963962-CAC5-4C0D-AB01-B8245CD60D85Q39200222-054EC718-1B43-4A21-9D08-6A00D6108BEDQ40093103-75098864-AE6A-460C-805E-319A02FC5685Q41399522-444552CE-3461-4499-B5A7-0FE5AAB8FCA6Q41686335-84958890-5500-41EC-A6FD-F1AA5CCB1F68Q43687415-2749024D-35C5-41D8-8CA4-7F0B94725E77Q47109204-FBF5648F-3228-4F47-8842-B9C899384225Q47562356-75B57500-B34B-4873-BBC9-E772AAE4F217Q47927859-928405C9-E52F-4B4B-AEF8-36682DE9038BQ50880629-4D10EDAD-2335-4514-8E6C-E06DE4C669F9Q54264691-104F96DE-85F9-4C7F-90C7-FAAF698BA392Q58693717-21C142A6-6C6F-4735-A3BD-E4E9F8D3244DQ58770879-09E6622F-B8AD-48CA-9AA5-7AB3F0B31C62
P2860
Chronic obstructive airways disease following treated pulmonary tuberculosis.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Chronic obstructive airways disease following treated pulmonary tuberculosis.
@en
Chronic obstructive airways disease following treated pulmonary tuberculosis.
@nl
type
label
Chronic obstructive airways disease following treated pulmonary tuberculosis.
@en
Chronic obstructive airways disease following treated pulmonary tuberculosis.
@nl
prefLabel
Chronic obstructive airways disease following treated pulmonary tuberculosis.
@en
Chronic obstructive airways disease following treated pulmonary tuberculosis.
@nl
P1433
P1476
Chronic obstructive airways disease following treated pulmonary tuberculosis.
@en
P2093
Ferguson AD
Willcox PA
P304
P356
10.1016/S0954-6111(89)80031-9
P577
1989-05-01T00:00:00Z